一例患者免疫治疗期间具有高度同源 T 细胞受体序列的循环 TIL（肿瘤浸润淋巴细胞）库的分歧转录状态与动力学

Evidence has shown that T-cell receptors (TCRs) that recognize the same epitopes may not be the exact TCR clonotypes but have slightly different TCR sequences.

However, the changes in the genomic and transcriptomic signatures of these highly homologous T cells during immunotherapy remain unknown.

Here, we examined the evolutionary features in circulating TCR clonotypes observed in tumors (tumor-infiltrating lymphocyte (TIL)-TCRs) by combining single-cell RNA/TCR sequencing of longitudinal blood samples and TCR sequencing of tumor tissue from a patient treated with anti-cytotoxic T-lymphocyte-associated protein 4/programmed cell death protein-1 therapy.

We found frequent circulating CD8 + TIL-TCRs with identical complementarity determining region 3 (CDR3) amino acid sequences but quasi-identical CDR3 and TCR / (TRA/TRB) sequences.

Despite their sequence similarities, these highly homologous TIL-TCRs responded differently to immunotherapy, and exhibited distinct transcriptional signatures that were uniquely distinguished by the expression of GZMK Overall, the expression of IFNG in CD8 + T-cell subsets including highly homologous TIL-TCRs increased when the patient achieved a response, but gradually decreased as the patient developed acquired resistance.

Our findings provide insight into the cross-talk between T cells in the tumor microenvironment and those in the blood, and highlight that CD8 + T cells with highly homologous TCR sequences might display divergent transcriptional states and kinetics in response to immunotherapy.